• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

含1,2-苯并噻嗪结构的[1,3,4]噻二唑并[3,2-a][1,3,5]三嗪衍生物的合成及其抗肿瘤活性

赵小美, 王新, 汲霞, 张华, 张平平, 胡国强

赵小美, 王新, 汲霞, 张华, 张平平, 胡国强. 含1,2-苯并噻嗪结构的[1,3,4]噻二唑并[3,2-a][1,3,5]三嗪衍生物的合成及其抗肿瘤活性[J]. 中国药科大学学报, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
引用本文: 赵小美, 王新, 汲霞, 张华, 张平平, 胡国强. 含1,2-苯并噻嗪结构的[1,3,4]噻二唑并[3,2-a][1,3,5]三嗪衍生物的合成及其抗肿瘤活性[J]. 中国药科大学学报, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
ZHAO Xiaomei, WANG Xin, JI Xia, ZHANG Hua, ZHANG Pingping, HU Guoqiang. Synthesis and antitumor activities of 1, 2-benzothiazines[1, 3, 4]thiadiazolo[3, 2-a][1, 3, 5]triazin derivatives[J]. Journal of China Pharmaceutical University, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104
Citation: ZHAO Xiaomei, WANG Xin, JI Xia, ZHANG Hua, ZHANG Pingping, HU Guoqiang. Synthesis and antitumor activities of 1, 2-benzothiazines[1, 3, 4]thiadiazolo[3, 2-a][1, 3, 5]triazin derivatives[J]. Journal of China Pharmaceutical University, 2020, 51(1): 24-28. DOI: 10.11665/j.issn.1000-5048.20200104

含1,2-苯并噻嗪结构的[1,3,4]噻二唑并[3,2-a][1,3,5]三嗪衍生物的合成及其抗肿瘤活性

基金项目: 山东省高校科研计划资助项目(No.J18KB122);齐鲁医药学院应用药学科研创新平台资助项目(No.2018ZBXC423)

Synthesis and antitumor activities of 1, 2-benzothiazines[1, 3, 4]thiadiazolo[3, 2-a][1, 3, 5]triazin derivatives

  • 摘要: 以吡罗昔康合成中间体(CAS:35511-15-0)为原料,利用活性拼接等药物设计原理,设计并合成了9个结构新颖的目标化合物,其结构经1H NMR、MS等表征。通过测定对胰腺癌细胞Capan-1、白血病细胞L1210和人肝癌细胞SMMC-7721的抑制活性,评价目标化合物的体外抗肿瘤活性。结果表明,化合物 6f (IC50=2.4±0.5 μmol/L)对胰腺癌细胞Capan-1表现出较好的抑制活性;化合物 6h (IC50=5.4±0.2 μmol/L)对白血病细胞L1210表现出较好的抑制活性;化合物 6g (IC50=3.8±0.2 μmol/L)对人肝癌细胞SMMC-7721表现出较好的抑制活性。初步的抗肿瘤活性实验结果表明,将吡罗昔康3位的侧链替代为噻二唑并三嗪侧链,对提高该类化合物的抗肿瘤活性有一定的作用。
    Abstract: Based on the drug design principle of reactive functional group splicing, nine novel title compounds were designed and synthesized with piroxicam intermediate as the starting material. Their structures were characterized by 1H NMR and MS analysis. The in vitro antitumor activity evaluation suggested that compounds 6f , 6h and 6g exhibited good inhibitory reactivity on pancreatic cancer cell line Capan-1(IC50=2. 4±0. 5 μmol/L), leukemia cell line L1210(IC50=5. 4±0. 2 μmol/L), and human liver cancer cell line SMMC-7721(IC50=3. 8±0. 2 μmol/L), respectively. The introduction of thiadiazolo[3, 2-a]triazine side chain could improve the antitumor activity of these compounds.
  • [1] Vidovi′c D,Schürer SC.Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design[J].J Med Chem,2009,52(21):6649-6659.
    [2] Stairs DB,Bayne LJ,Rhoades B,et al.Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene[J].Cancer Cell,2011,19(4):470-483.
    [3] Chen H,Gu YJ,Yuan XG,et al.Synthesis and antifungal,anti-tumor studies of the trisubstitued triazines bearing aminopyrimidine group[J].Chin J Org Chem(有机化学),2011,31(8):1266-1271.
    [4] Li W,Guo SM,Chen AH,et al.Synthesis of 4-phenyl-1,3,5-triazine-2-amine derivatives and their antitumor activities in vitro[J].Drugs Clin(现代药物与临床),2019,34(8):2252-2257.
    [5] Liu ZX. Design, synthesis and biological activities of novel PARP-1 inhibitors with pyrazolotriazinone skeleton(吡咯并三嗪酮类PARP-1抑制剂的设计、合成及生物活性)[D].Jiangsu:Nanjing University of Chinese Medicine,2017.
    [6] Gao LZ,Li T,Xie YS,et al.Design,synthesis,antibacterial and anti-cell proliferation activities of[1,2,4] triazino[3,4-h][1,8] naphthyridine-8-one-7-carboxylic acid derivatives[J].Acta Pharm Sin(药学学报),2015,50(3):332-336.
    [7] Zhang TY.Dihydrotriazin and pyrimidin guanidine derivatives as anti-bacterial agents;ursolic acid derivatives as PTP1B inhibitory.Design,synthesis and biological evalution(二氢三嗪类及嘧啶胍类衍生物的设计合成及抗菌活性研究&熊果酸衍生物的设计合成及PTP1B抑制活性研究)[D].Jilin:Yanbian University,2017.
    [8] Li CJ,Le ZP,Zhao CS.Synthesis and antidiabetic activities of novel pyrrolotriazine compounds as DPP-4 inhibitors[J].Chin J New Drugs(中国新药杂志),2014,23(18):2195-2202.
    [9] Zhao Y,Hou J,Zhang QG,et al.Synthesis and acetylcholinesterase inhibitory activity of 6-benzyl-3-aryl-7H-thiazolo[3,2-b]-1,2,4-triazin-7-one derivatives[J].Chin Pharm J(中国药学杂志),2018,53(8):579-584.
    [10] Jin Z.Synthesis and biological evaluation of 3,6-diaryl-7H-thiazolo[3,2,-b][1,2,4] thiazin-7- one derivatives as acetylcholinesterase inhibitors archives of pharmacel resesrch(3,6-二芳基噻唑并三嗪类化合物的设计合成及生物活性研究)[D].Liaoning:Shenyang Pharmaceutical University,2010.
    [11] Zheng XT.Synthesis of noval sulfonamide-1,3,5-triazine derivatives and their protective effects on heart function(新型磺胺-1,3,5-三嗪衍生物的合成及其对心脏功能的保护作用研究)[D].Guangdong:Southern Medical University,2014.
    [12] Wang LY,Hou J,Zhang Y.Clinical study on levetiracetam combined with lamotrigine in the treatment of elderly patients with epilepsy[J].China Prac Med(中国实用医药),2018,13(5):3-5.
    [13] Jia N. Clinical trial of lamotrigine combined with sodium valproate in the treatment of children esilepsy[J].Chin J Clin Pharmacol(中国临床药理学杂志),2016,32(14):1293-1295.
    [14] Zhang FY. A comparative study of duloxetine combined with lamotrigine in the treatment of patients with treatment-resistant depression(度洛西汀联合拉莫三嗪治疗难治性抑郁症对照研究)[D].Shandong:Qingdao University,2017.
    [15] Ji BW.Study of lamotrigine efficacy on patients with epilepsy incorporate in depressive disorder(拉莫三嗪治疗癫痫合并抑郁障碍患者的疗效研究)[D].Yunnan:Kunming Medical University,2012.
    [16] Yang F.Antidepressant-like effects of fluoxetine combined with lamotrigine in forced stress and chronic mild stress depression model in mice(氟西汀联合拉莫三嗪抗小鼠强迫应激及慢性应激诱导的抗抑郁作用研究)[D].Jilin:Yanbian University,2015.
    [17] Wang X,Zhao XM,Zhang PP,et al.Synthesis and antitumor activity of 1,2-benzothiazines imidazolo[1,2-b][1,3,4] triazazole derivatives[J].J China Pharm Univ(中国药科大学学报),2019,50(5):540-543.
  • 期刊类型引用(3)

    1. 张俊丽,曹俊如,张瑶瑶,鲁胜男,苏峰,何广卫. siRNA纳米递药系统在胶质瘤治疗中的研究进展. 医药前沿. 2024(34): 52-57 . 百度学术
    2. 张琼丹,陈朝霞,李芾瑶,张宇. siRNA纳米递送系统研究进展. 生物化学与生物物理进展. 2022(06): 1018-1035 . 百度学术
    3. 王悦,黄元政,朱丹丹,廉宝平,刘潇璇. 基于聚酰胺类树形分子前药的纳米给药系统在恶性肿瘤治疗中的应用. 中南药学. 2021(07): 1343-1352 . 百度学术

    其他类型引用(1)

计量
  • 文章访问数:  501
  • HTML全文浏览量:  0
  • PDF下载量:  1110
  • 被引次数: 4
出版历程
  • 刊出日期:  2020-02-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭